|Videos|September 24, 2020

Financial planning during a pandemic: Part I

John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, speak on how ophthalmologists should be working on or revisiting their financial plans six months into the ongoing coronavirus pandemic and ahead of a possible second wave, as well as the potential financial repercussions the economy may face.

John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, speak with Ophthalmology Times®' Sheryl Stevenson on how ophthalmologists should be working on or revisiting their financial plans six months into the ongoing coronavirus pandemic and ahead of a potential second wave, as well as the financial repercussions the economy may face.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Financial planning during a pandemic: Part I

Related Content

Why aren’t there enough ophthalmologists?

Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD

ARVO 2026: Scalable pipeline for data extraction from ophthalmic clinical letters

Bridging borders in ophthalmology: Reflections on international medical training

What helps glaucoma patients better adhere to their treatment?

Latest CME

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

(COPE Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Reducing Treatment Burden in Retinal Disease Care With Extended-Duration Anti-VEGF Therapies

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

(CME Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

Trending on Eye Care Network - Ophthalmology Times

EURETINA 2026: Uveitis or retinitis pigmentosa? Ester Carreño, MD, PhD, on mimics

EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease

EURETINA 2026: Gene therapy sessions to watch in Vienna

What retinal imaging reveals about the brain-eye connection with Sharon Fekrat, MD, FACS, FASRS

MOGENRY earns Japan priority review for inherited retinal dystrophies